Takeda has joined forces with Iambic Therapeutics on a multiyear collaboration to use the US biotech's AI-driven, structure-based drug discovery platform to find new therapies for gastrointestinal and inflammatory diseases, as well as cancer.
A study suggests that artificial intelligence (AI) showed comparable performance to dermatologists in detecting melanoma, with similar sensitivity and specificity in prospective clinical studies.
Experts often consider melanoma to be the most serious type of skin cancer due to the likelihood of metastasizing.
Read more here.
The further Apple dives into medical technology, the more it will have to deal with regulators. Now, the App Store will label apps that meet select criteria for medical devices in the US, EU, and UK.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us